Causes of death in HIV infection: the key determinant to define the clinical response to anti-HIV therapy

Amanda Mocroft, Jose Gatell, Peter Reiss, Bruno Ledergerber, Ole Kirk, Stefano Vella, Anders Blaxhult, Andrew N. Phillips, Jens Lundgren

Research output: Contribution to journalArticleAcademicpeer-review

40 Citations (Scopus)

Abstract

Studies have shown an increased risk of new AIDS/death among injecting drug users (IDU) starting highly active antiretroviral therapy (HAART). Of 3872 patients starting HAART in the EuroSIDA study, 819 were IDU (21.2%). During 14 769 person-years of follow-up, 499 patients progressed to new AIDS/death. Compared with homosexual individuals, IDU had an increased incidence of new AIDS/death, but only for non-HIV deaths. There is an urgent need to define and standardize causes of death in observational studies
Original languageEnglish
Pages (from-to)2333-2337
JournalAIDS (London, England)
Volume18
Issue number17
DOIs
Publication statusPublished - 2004

Cite this